Alexandria Real Estate Equities
ARE
#2269
Rank
NZ$13.96 B
Marketcap
NZ$80.79
Share price
-3.78%
Change (1 day)
-52.80%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Market capitalization of Alexandria Real Estate Equities (ARE)

Market cap: NZ$13.96 Billion

As of December 2025 Alexandria Real Estate Equities has a market cap of NZ$13.96 Billion. This makes Alexandria Real Estate Equities the world's 2269th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alexandria Real Estate Equities from 1997 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$13.96 B-54.18%
2024NZ$30.47 B-12.51%
2023NZ$34.83 B-7.47%
2022NZ$37.64 B-27.02%
2021NZ$51.58 B54.78%
2020NZ$33.33 B15%
2019NZ$28.98 B51.96%
2018NZ$19.07 B7.58%
2017NZ$17.72 B39.15%
2016NZ$12.74 B33.02%
2015NZ$9.57 B18.34%
2014NZ$8.09 B46.89%
2013NZ$5.51 B3.39%
2012NZ$5.32 B-2.66%
2011NZ$5.47 B4.89%
2010NZ$5.21 B34.49%
2009NZ$3.88 B15.82%
2008NZ$3.35 B-20.11%
2007NZ$4.19 B1.45%
2006NZ$4.13 B56.43%
2005NZ$2.64 B29.33%
2004NZ$2.04 B19.1%
2003NZ$1.71 B11.1%
2002NZ$1.54 B-4.59%
2001NZ$1.61 B24.06%
2000NZ$1.30 B55.93%
1999NZ$0.83 B13.25%
1998NZ$0.73 B17.06%
1997NZ$0.63 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Alexandria Real Estate Equities was reported to be:

NZ$13.95 Billion
by Nasdaq info icon info icon
NZ$13.96 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$253.39 B 1,714.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$263.83 B 1,789.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.577 T 11,194.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$34.12 B 144.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$183.39 B 1,213.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$317.63 B 2,174.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$106.60 B 663.52%๐Ÿ‡บ๐Ÿ‡ธ USA